Hoechst Marion Roussel, Inc.; Carderm Capital L.P.; and Andrx Corporation

Last Updated:
In the Matter of Hoechst Marion Roussel, Inc.; Carderm Capital L.P.; and Andrx Corporation
FTC Matter/File Number:

9810368

Docket Number:

9293

Enforcement Type:

Part III Administrative Complaint

Case Summary

A consent order settled allegations in an administrative complaint that charged that Hoechst agreed to pay Andrx Corporation millions of dollars not to market and distribute a generic version of Hoechst’s branded Cardizem CD, a once-a-day diltiazem drug product used in the treatment of hypertension and angina. The consent order prohibits the companies from entering into agreements designed to restrict the entry of generic competitors in an attempt to monopolize relevant markets .